A review on targeted therapies for lung cancer

A review on targeted therapies for lung cancer

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Bibliografische gegevens
Hoofdauteur:	Ashraf, Anushey
Andere auteurs:	Khan, Tanisha Tabassum Sayka
Formaat:	Thesis
Taal:	English
Gepubliceerd in:	Brac University 2023
Onderwerpen:	Lung cancer Antibodies Targeted therapy Vaccines Lung cancer > Treatment
Online toegang:	http://hdl.handle.net/10361/19353

Gelijkaardige items

Immunotherapy in the Management of Lung Cancer
door: Tasnim, Humayra
Gepubliceerd in: (2022)

Potential of liposomes for the treatment of lung cancer- a review
door: Mim, Shanzida
Gepubliceerd in: (2023)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
door: Tania, Umme
Gepubliceerd in: (2023)

Molecules associated with the development of lung cancer
door: Rahman, Adree, et al.
Gepubliceerd in: (2023)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
door: Paul, Pulock
Gepubliceerd in: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
door: Rahman, Tasnim
Gepubliceerd in: (2024)

A review on recent advances in drugs for lung cancer treatment
door: Noor, Fouzia
Gepubliceerd in: (2024)

Protein biomarkers for Lung Cancer: a bioinformatic approach
door: Jeba, Joynob
Gepubliceerd in: (2017)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
door: Razna, Amrin Islam
Gepubliceerd in: (2019)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
door: Flora, Sanzida Alam
Gepubliceerd in: (2024)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
door: Pial, Sazia Afrin
Gepubliceerd in: (2018)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
door: Zangmo, Thinley
Gepubliceerd in: (2024)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
door: Hoque, Ismoth Ara
Gepubliceerd in: (2024)

A case study of lung cancer patients in term of various risk factors in context of Bangladesh
door: Shabnam, Musharrat
Gepubliceerd in: (2018)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
door: Bristy, Israt Zerin
Gepubliceerd in: (2021)

Targeted therapeutic options in the treatment of Breast Cancer
door: Alam, Kazi Tasnuva
Gepubliceerd in: (2022)

Lung cancer detection and classification using machine learning
door: Arefin, Mahbubul, et al.
Gepubliceerd in: (2023)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
door: Das, Reshita
Gepubliceerd in: (2024)

RIPK pathway, as a potential target, for cancer treatment - a review
door: Jahan, Nusrat
Gepubliceerd in: (2024)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
door: Nandy, Aditi
Gepubliceerd in: (2022)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
door: Mukti, Roushney Fatima, et al.
Gepubliceerd in: (2016)

Therapeutic prospective of targeting calcium homeostasis in cancer – a review
door: Kamal, Tasnova
Gepubliceerd in: (2019)

A review on nanoparticles based drug delivery in cancer treatment: advantages & challenges
door: Nahar, Kamrun
Gepubliceerd in: (2023)

A review of next-generation immuno-oncology agents for cancer therapy: recent dictation shifts in cancer immunotherapy
door: Ratu, Tabassum
Gepubliceerd in: (2024)

A review on carbon nanotube: a new era in cancer diagnosis & therapy
door: Parvez, Safi
Gepubliceerd in: (2023)

SHP2 inhibitors: Recent advancements and potential breakthroughs in cancer therapy
door: Meem, Manila
Gepubliceerd in: (2023)

A comprehensive review on drug repurposing in cancer treatment
door: Sarkar, Onusree
Gepubliceerd in: (2024)

The impact of cell penetrating peptides in prospective cancer therapy: a review
door: Nashrah, Zannatul
Gepubliceerd in: (2023)

Breast cancer therapy through Liposomal drug delivery system
door: Ome, Nusrat Jahan
Gepubliceerd in: (2024)

Trend in approval of targeted biologics in the last two decades
door: Siddika, Khadiza
Gepubliceerd in: (2024)

An examination of therapeutic synergy: a comprehensive meta-analysis comparing the efficacy of TAS-102 and FOLFOX as a combination therapy for colon cancer
door: Hasan, Amit
Gepubliceerd in: (2024)

Current practice and approaches of immunotherapy in Cancer treatment
door: Khondokar, Faiza
Gepubliceerd in: (2022)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
door: Karim, Samia Binte
Gepubliceerd in: (2024)

Benign Prostatic Hyperplasia & Prostate Cancer: a review on the treatment strategies
door: Alam, Tahera
Gepubliceerd in: (2024)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
door: Abir, Shifaty Nur
Gepubliceerd in: (2024)

A review paper on Nanotechnology based strategies in the treatment of cancer
door: Rahman, Samia
Gepubliceerd in: (2022)

A review on potential of PARP inhibitors in the treatment of prostate cancer
door: Islam, Saidul
Gepubliceerd in: (2022)

The uses of bacteria in cancer therapy
door: Saha, Shimul, et al.
Gepubliceerd in: (2021)

Drug repurposing: potential of Antimicrobial Drugs in Breast Cancer Treatment
door: Chakraborty, Anuradha
Gepubliceerd in: (2024)

Concepts and challenges of biosimilars to mitigate the oncology drug expenses
door: Tania, Umme
Gepubliceerd in: (2021)